Blue Spoon Consulting Group, LLC, today published a white paper that provides context for the pharmaceutical industry to reorient itself strategically. As momentum grows for performance-based contracting and bulk buying pools, drug companies will need new kinds of strategic ideas that simultaneously create markets and improve health outcomes. Available for download through the Blue Spoon Consulting website, this white paper helps develop perspective and approach.
Blue Spoon is a strategy and marketing consultancy for the pharmaceutical industry. We are at the leading edge with a framework to help clients innovate their tactics, differentiate their strategies, and create at a system level. Simply put, Blue Spoon is different. We deliver an evolutionary leap in solutions for growth and competitive advantage. Visit: www.bluespoonconsulting.com.